Literature DB >> 25349815

Flare up of rheumatoid arthritis associated with Vogt-Koyanagi-Harada syndrome treated with leflunomide.

Jia Wang1, Qi-Bing Xie2, Yi Zhao2, Yi Liu2.   

Abstract

Entities:  

Year:  2014        PMID： 25349815      PMCID： PMC4206903          DOI： 10.3980/j.issn.2222-3959.2014.05.30

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN： 2222-3959            Impact factor:   1.779


× No keyword cloud information.
  7 in total

1.  STAT4 polymorphism in a Chinese Han population with Vogt-Koyanagi-Harada syndrome and Behçet's disease.

Authors:  Ke Hu; Peizeng Yang; Zhengxuan Jiang; Shengping Hou; Liping Du; Fuzhen Li
Journal:  Hum Immunol       Date:  2010-05-14       Impact factor: 2.850

2.  Early clinical experience with leflunomide in uveitis.

Authors:  Mili Roy
Journal:  Can J Ophthalmol       Date:  2007-08       Impact factor: 1.882

Review 3.  A look at autoimmunity and inflammation in the eye.

Authors:  Rachel R Caspi
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

4.  The Th17/Treg imbalance and cytokine environment in peripheral blood of patients with rheumatoid arthritis.

Authors:  Wenhong Wang; Shihe Shao; Zhijun Jiao; Mingquan Guo; Huaxi Xu; Shengjun Wang
Journal:  Rheumatol Int       Date:  2011-01-11       Impact factor: 2.631

5.  Association of the CTLA-4 gene with Vogt-Koyanagi-Harada syndrome.

Authors:  Liping Du; Peizeng Yang; Shengping Hou; Xiaomin Lin; Hongyan Zhou; Xiangkun Huang; Li Wang; Aize Kijlstra
Journal:  Clin Immunol       Date:  2008-02-20       Impact factor: 3.969

6.  The potential of newer immunomodulating drugs in the treatment of uveitis: a review.

Authors:  J Salzmann; S Lightman
Journal:  BioDrugs       Date:  2000-06       Impact factor: 5.807

Review 7.  Vogt-Koyanagi-Harada syndrome.

Authors:  A Greco; M Fusconi; A Gallo; R Turchetta; C Marinelli; G F Macri; A De Virgilio; M de Vincentiis
Journal:  Autoimmun Rev       Date:  2013-04-06       Impact factor: 9.754
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.